Adele Blackler, PhD

Adele Blackler, PhD has a diverse range of work experience in the field of translational medicine and clinical development. Adele is currently working at BioAI Health, starting in February 2023. Previously, Adele worked at Strata Oncology as the Director of Translational Medicine from April 2022 to September 2022. In this role, they played a key role in the clinical development of pan-tumor diagnostic trials, implemented a new strategy for clinical validation, and developed a novel therapeutic-response monitoring diagnostic test.

Before their time at Strata Oncology, Adele served as the Director of Clinical Development at Roche from October 2021 to March 2022. Prior to that, at ArcherDX, Inc., they held the position of Director of HEOR and Translational Medicine from January 2020 to October 2021. During this time, they contributed to the launch of an IVD CDx and provided scientific expertise for multiple research studies.

Adele also has experience in strategic consulting, having worked as a Strategic Consultant at First Principles Advisory Group from May 2018 to December 2019. Additionally, they worked at Biodesix, Inc., where they held the role of Director of Clinical Development and Medical Affairs from May 2017 to April 2018. In this role, they managed cross-functional teams and developed a company-wide sample management process.

Prior to their work at Biodesix, Adele served as the Laboratory Director at RM3 Labs from June 2016 to May 2017. Adele also held positions at OncoPlex Diagnostics as the Associate Director of R&D and Medical Affairs from June 2015 to February 2016, where they led business development, product development, and medical affairs initiatives.

Adele began their career as a post-doctoral fellow at the National Cancer Institute (NCI) from January 2011 to October 2013. During this time, they focused on assay development and optimization for high-throughput proteomic analysis.

Overall, Adele Blackler, PhD has a strong background in translational medicine, clinical development, and strategic consulting, with experience in leading cross-functional teams, launching diagnostic products, and providing scientific expertise in various research studies.

Adele Blackler, PhD, holds a Ph.D in Pharmacology from the University of Colorado Anschutz Medical Campus. Adele obtained a Bachelor of Science degree with a major in Chemistry and Mathematics from the Colorado School of Mines. No specific start or end years are provided for either their Ph.D or undergraduate studies.